Suchergebnisse - "Smyth, Duncan"

PubPharm (27)

1

Reply : Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation

enthalten in: Brain : a journal of neurology | 2024

von Keddie, S. | Smyth, D. | Keh, R. | +7

CommentOn: Brain. 2024 Jan 4;147(1):e1-e2. - PMID 37587331

2

Peripherin is a biomarker of axonal damage in peripheral nervous system disease

enthalten in: Brain : a journal of neurology | 2023

von Keddie, S. | Smyth, D. | Keh, R. | +13

CommentIn: Brain. 2024 Jan 4;147(1):e1-e2. - PMID 37587331

3

Toxic neuropathies : a practical approach

enthalten in: Practical neurology | 2023

von Smyth, D. | Kramarz, C. | Carr, A. | +2

4

The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barré syndrome

enthalten in: Journal of the peripheral nervous system : JPNS | 2023

von McGonigal, R. | Cunningham, M. | Smyth, D. | +7

5

Vestibular migraine treatment : a comprehensive practical review

enthalten in: Brain : a journal of neurology | 2022

von Smyth, D. | Britton, Z. | Murdin, L. | +2

6

Comprehensive Diagnosis and Management of POEMS Syndrome

enthalten in: HemaSphere | 2022

von D'Sa, S. | Khwaja, J. | Keddie, S. | +10

7

Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndrome

enthalten in: EJHaem | 2022

von Khwaja, J. | Keh, R. | Smyth, D. | +3

8

Bilateral Vestibular Failure May Improve With Treatment of the Underlying Condition : A Report of 2 Cases

enthalten in: The neurologist | 2021

von Smyth, D. | Mossman, S.

9

Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies

enthalten in: Journal of the neurological sciences | 2021

von Smyth, D. | Kyaw, K. | Legister, A. | +6

10

Correction to : Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2021

von Wieske, L. | Smyth, D. | Lunn, M. | +2

ErratumFor: Neurotherapeutics. 2021 Oct;18(4):2351-2367. - PMID 34661878